This study may help to better understand the molecular mechanisms of drug resistance in breast cancer, and it may imply that overexpression of miR-129-5p alone or in conjunction with HMGB1 interference, is a promising strategy to combat multidrug resistance in breast cancer. This evidence concerns the gene HMGB1 and breast cancer.